Purdue Pharma's Ultram Patents Deemed Invalid
Judge Kent A. Jordan of the U.S. District Court for the District of Delaware determined Friday that the patents were infringed, but that they were invalid due to obviousness.
The judge rejected arguments that the patents were unenforceable for inequitable conduct, however.
Prior art for the drug, known under the scientific name...
To view the full article, register now.